Carbidopa, Levodopa and Entacapone
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CARBIDOPA, LEVODOPA AND ENTACAPONE TABLETS safely and effectively. See full prescribing information for CARBIDOPA, LEVODOPA AND ENTACAPONE TABLETS.CARBIDOPA, LEVODOPA AND ENTACAPONE TABLETS, for oral use Initial U.S. Approval: 2003
f0d9d7a8-1d06-4119-b2bc-42b3ec08d45b
HUMAN PRESCRIPTION DRUG LABEL
Apr 24, 2025
Macleods Pharmaceuticals Limited
DUNS: 862128535
Products 6
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Carbidopa, Levodopa and Entacapone
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (15)
Carbidopa, Levodopa and Entacapone
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (15)
Carbidopa, Levodopa and Entacapone
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (15)
Carbidopa, Levodopa and Entacapone
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (15)
Carbidopa, Levodopa and Entacapone
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (15)
Carbidopa, Levodopa and Entacapone
Product Details
FDA regulatory identification and product classification information